Large discrepancies in payments disclosed by patient groups and major drug companies are highlighted in a new report published today—Sunday 20 September 2020.
Sep 21, 2020
0
2
A drug company said Friday that a medicine it sells to tamp down inflammation has helped prevent the need for breathing machines in hospitalized COVID-19 patients in the first large study that primarily enrolled Hispanics ...
Sep 18, 2020
0
2
AstraZeneca is resuming clinical trials for the COVID-19 vaccine, ChAdOx1 nCoV-19, following confirmation that is safe to do so. The trials were paused when one of the participants developed an "unexplained illness."
Sep 16, 2020
0
3
A drug company says that partial results from a study testing an antibody drug give hints that it may help keep mild to moderately ill COVID-19 patients from needing to be hospitalized, a goal no current coronavirus medicine ...
Sep 16, 2020
0
0
A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized COVID-19 patients shortens their time to recovery by an additional day.
Sep 14, 2020
0
7
New research suggests that COVID-19 is far from benign when it strikes young adults: Once they are hospitalized, 1 in 5 wind up in the ICU and many need ongoing medical care even after they are free of the virus, scientists ...
Sep 11, 2020
0
53
THURSDAY, Sept. 10, 2020 (Healthday News)—Just weeks into the fall semester, universities and colleges in all 50 states are now struggling to contain the spread of coronavirus on their campuses.
Sep 10, 2020
0
7
New research led by the University of South Australia shows that a blanket approach to prescribing medication during pregnancy may put low birth weight babies at risk for the rest of their lives.
Sep 8, 2020
0
4
The CEOs of nine companies developing vaccines against COVID-19 on Tuesday pledged to "uphold the integrity of the scientific process" amid concern Donald Trump will pressure regulators to approve a vaccine ahead of the presidential ...
Sep 8, 2020
0
3
Conventional drug costing models are unlikely to apply when it comes to putting a price tag on a vaccine against COVID-19 for Canadians, according to health economist Christopher McCabe of the University of Alberta's Faculty ...
Sep 3, 2020
0
2
